An unbalanced PD-L1/CD86 ratio in CD14 ++ CD16 + monocytes is correlated with HCV viremia during chronic HCV infection

Cellular and Molecular Immunology

Volumn 11, Issue 3, 2014, Pages 294-304

  Zheng, Jiajia ^a,b   Liang, Hua ^c   Xu, Chunhui ^a   Xu, Qiang ^a   Zhang, Ting ^a   Shen, Tao ^a   Lu, Fengmin ^a  

^a PEKING UNIVERSITY   (China)

^b PEKING UNIVERSITY THIRD HOSPITAL   (China)

^c CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

core antigen; hepatitis C virus; monocytes; PD L1 CD86; viral load

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; B7 ANTIGEN; CD14 ANTIGEN; CD16 ANTIGEN; CD86 ANTIGEN; GAMMA GLUTAMYLTRANSFERASE; HEPATITIS C ANTIGEN; HEPATITIS C CORE ANTIGEN; HLA DR ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; PROGRAMMED DEATH 1 LIGAND 1; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VIRUS RNA; BIOLOGICAL MARKER; CD274 PROTEIN, HUMAN; CD86 PROTEIN, HUMAN; CYTOKINE; FC RECEPTOR; LIGAND;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CELLULAR IMMUNITY; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE ASSOCIATION; DISEASE COURSE; DOWN REGULATION; FEMALE; GENOTYPE; HEPATITIS C; HUMAN; IMMUNE STATUS; IMMUNOMODULATION; IMMUNOPHENOTYPING; LIGAND BINDING; MAJOR CLINICAL STUDY; MALE; MONOCYTE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN EXPRESSION; VIRAL CLEARANCE; VIREMIA; VIRUS LOAD; VIRUS REPLICATION; CASE CONTROL STUDY; CHRONIC HEPATITIS C; DEMOGRAPHY; HEPACIVIRUS; IMMUNOLOGY; METABOLISM; MIDDLE AGED; VIROLOGY;

ADULT; ANTIGENS, CD14; ANTIGENS, CD274; ANTIGENS, CD86; BIOMARKERS; CASE-CONTROL STUDIES; CYTOKINES; DEMOGRAPHY; FEMALE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; IMMUNOPHENOTYPING; LIGANDS; MALE; MIDDLE AGED; MONOCYTES; RECEPTORS, IGG; TOLL-LIKE RECEPTORS; VIREMIA;

EID: 84899872259     PISSN: 16727681     EISSN: None     Source Type: Journal    
DOI: 10.1038/cmi.2013.70     Document Type: Article

References (45)

1. Bowen DG, Walker CM. The origin of quasispecies: Cause or consequence of chronic hepatitis C viral infection? J Hepatol 2005; 42: 408-417.
2. Bowen DG, Walker CM. Adaptive immune responses in acute and chronic hepatitis C virus infection. Nature 2005; 436: 946-952.
3. Hahn YS. Subversion of immune responses by hepatitis C virus: Immunomodulatory strategies beyond evasion? Curr Opin Immunol 2003; 15: 443-449.
4. Hoofnagle JH. Hepatitis C: The clinical spectrum of disease. Hepatology 1997; 26: 15S-20S.
5. Claassen MA, Janssen HL, Boonstra A. Role of T cell immunity in hepatitis C virus infections. Curr Opin Virol 2013; 3: 461-467.
6. Liu B, Woltman AM, Janssen HL, Boonstra A. Modulation of dendritic cell function by persistent viruses. J Leukoc Biol 2009; 85: 205-214.
7. Tacke RS, Tosello-Trampont A, Nguyen V, Mullins DW, Hahn YS. Extracellular hepatitis C virus core protein activates STAT3 in human monocytes/macrophages/dendritic cells via an IL-6 autocrine pathway. J Biol Chem 2011; 286: 10847-10855.
8. Cros J, Cagnard N, Woollard K, Patey N, Zhang SY, Senechal B et al. Human CD14dim monocytes patrol and sense nucleic acids and viruses via TLR7 and TLR8 receptors. Immunity 2010; 33: 375-386.
9. van de Veerdonk FL, Netea MG. Diversity: A hallmark of monocyte society. Immunity 2010; 33: 289-291.
10. Ziegler-Heitbrock L, Ancuta P, Crowe S, Dalod M, Grau V, Hart DN et al. Nomenclature of monocytes and dendritic cells in blood. Blood 2010; 116: E74-e80.
11. Wedemeyer H, He XS, Nascimbeni M, Davis AR, Greenberg HB, Hoofnagle JH et al. Impaired effector function of hepatitis C virusspecific CD81 T cells in chronic hepatitis C virus infection. J Immunol 2002; 169: 3447-3458.
12. Gruener NH, Lechner F, Jung MC, Diepolder H, Gerlach T, Lauer G et al. Sustained dysfunction of antiviral CD81 T lymphocytes after infection with hepatitis C virus. J Virol 2001; 75: 5550-5558.
13. Huang X, Venet F, Wang YL, Lepape A, Yuan Z, Chen Y et al. PD-1 expression by macrophages plays a pathologic role in altering microbial clearance and the innate inflammatory response to sepsis. Proc Natl Acad Sci USA 2009; 106: 6303-6308.
14. Muhlbauer M, Fleck M, Schutz C, Weiss T, Froh M, Blank C et al. PDL1 is induced in hepatocytes by viral infection and by interferon-Alpha and-gamma and mediates T cell apoptosis. J Hepatol 2006; 45: 520-528.
15. Yao S, Wang S, Zhu Y, Luo L, Zhu G, Flies S et al. PD-1 on dendritic cells impedes innate immunity against bacterial infection. Blood 2009; 113: 5811-5818.
16. Shen T, Chen X, Chen Y, Xu Q, Lu F, Liu S. Increased PD-L1 expression and PD-L1/CD86 ratio on dendritic cells were associated with impaired dendritic cells function in HCV infection. J Med Virol 2010; 82: 1152-1159.
17. Geissmann F, Manz MG, Jung S, Sieweke MH, Merad M, Ley K. Development of monocytes, macrophages, and dendritic cells. Science 2010; 327: 656-661.
18. Ziegler-Heitbrock L. The CD141 CD161 blood monocytes: Their role in infection and inflammation. J Leukoc Biol 2007; 81: 584-592.
19. Moniuszko M, Bodzenta-Lukaszyk A, Kowal K, Lenczewska D, Dabrowska M. Enhanced frequencies of CD1411CD161, but not CD141CD161, peripheral blood monocytes in severe asthmatic patients. Clin Immunol 2009; 130: 338-346.
20. Zhang JY, Zou ZS, Huang A, Zhang Z, Fu JL, Xu XS et al. Hyperactivated pro-inflammatory CD16 monocytes correlate with the severity of liver injury and fibrosis in patients with chronic hepatitis B. PLoS ONE 2011; 6: E17484.
21. Han J, Wang B, Han N, Zhao Y, Song C, Feng X et al. CD14highCD161 rather than CD14lowCD161 monocytes correlate with disease progression in chronic HIV-infected patients. J Acquir Immune Defic Syndr 2009; 52: 553-559.
22. Auffray C, Sieweke MH, Geissmann F. Blood monocytes: Development, heterogeneity, and relationship with dendritic cells. Annu Rev Immunol 2009; 27: 669-692.
23. Belge KU, Dayyani F, Horelt A, Siedlar M, Frankenberger M, Frankenberger B et al. The proinflammatory CD141CD161DR11 monocytes are a major source of TNF. J Immunol 2002; 168: 3536-3542.
24. Hijdra D, Vorselaars AD, Grutters JC, Claessen AM, Rijkers GT. Phenotypic characterization of human intermediate monocytes. Front Immunol 2013; 4: 339.
25. Tacke F, Randolph GJ. Migratory fate and differentiation of blood monocyte subsets. Immunobiology 2006; 211: 609-618.
26. Liaskou E, Zimmermann HW, Li KK, Oo YH, Suresh S, Stamataki Z et al. Monocyte subsets in human liver disease show distinct phenotypic and functional characteristics. Hepatology 2012; 57: 385-398.
27. Skrzeczynska-Moncznik J, Bzowska M, Loseke S, Grage-Griebenow E, Zembala M, Pryjma J. Peripheral blood CD14high CD161 monocytes are main producers of IL-10. Scand J Immunol 2008; 67: 152-159.
28. Wong KL, Tai JJ, Wong WC, Han H, Sem X, Yeap WH et al. Gene expression profiling reveals the defining features of the classical, intermediate, and nonclassical human monocyte subsets. Blood 2011; 118: E16-e31.
29. Passacquale G, Vamadevan P, Pereira L, Hamid C, Corrigall V, Ferro A. Monocyte-platelet interaction induces a pro-inflammatory phenotype in circulating monocytes. PLoS ONE 2011; 6: E25595.
30. Freeman GJ, Long AJ, Iwai Y, Bourque K, Chernova T, Nishimura H et al. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J Exp Med 2000;192:1027-1034.
31. Okazaki T, Honjo T. The PD-1-PD-L pathway in immunological tolerance. Trends Immunol 2006; 27: 195-201.
32. Wang JM, Shi L, Ma CJ, Ji XJ, Ying RS, Wu XY et al. Differential regulation of interleukin-12 (IL-12)/IL-23 by Tim-3 drives TH17 cell development during hepatitis C virus infection. J Virol 2013; 87: 4372-4383.
33. Watanabe T, Bertoletti A, Tanoto TA. PD-1/PD-L1 pathway and T-cell exhaustion in chronic hepatitis virus infection. J Viral Hepat 2010; 17: 453-458.
34. Day CL, Kaufmann DE, Kiepiela P, Brown JA, Moodley ES, Reddy S et al. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 2006; 443: 350-354.
35. Rodig N, Ryan T, Allen JA, Pang H, Grabie N, Chernova T et al. Endothelial expression of PD-L1 and PD-L2 down-regulates CD81 T cell activation and cytolysis. Eur J Immunol 2003; 33: 3117-3126.
36. Jeong HY, Lee YJ, Seo SK, Lee SW, Park SJ, Lee JN et al. Blocking of monocyte-Associated B7-H1 (CD274) enhances HCV-specific T cell immunityinchronichepatitisCinfection. JLeukocBiol2008;83:755-764.
37. Abeles RD, McPhail MJ, Sowter D, Antoniades CG, Vergis N, Vijay GK et al. CD14, CD16 and HLA-DR reliably identifies human monocytes and their subsets in the context of pathologically reduced HLA-DR expression by CD14hi/CD16neg monocytes: Expansion of CD14hi/ CD16pos and contraction of CD14lo/CD16pos monocytes in acute liver failure. Cytometry A 2012; 81: 823-834.
38. Villacres MC, Literat O, DeGiacomo M, Du W, Frederick T, Kovacs A. Defective response to Toll-like receptor 3 and 4 ligands by activated monocytes in chronic hepatitis C virus infection. J Viral Hepat 2008; 15: 137-144.
39. Liu BS, Groothuismink ZM, Janssen HL, Boonstra A. Role for IL-10 in inducing functional impairment of monocytes upon TLR4 ligation in patients with chronic HCV infections. J Leukoc Biol 2011; 89: 981-988.
40. Martin-Blondel G, Gales A, Bernad J, Cuzin L, Delobel P, Barange K et al. Low interleukin-10 production by monocytes of patients with a self-limiting hepatitis C virus infection. J Viral Hepat 2009; 16: 485-491.
41. Peng C, Liu BS, de Knegt RJ, Janssen HL, Boonstra A. The response to TLR ligation of human CD161CD142 monocytes is weakly modulated as a consequence of persistent infection with the hepatitis C virus. Mol Immunol 2011; 48: 1505-1511.
42. Dong H, Zhu G, Tamada K, Chen L. B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion. Nat Med 1999; 5: 1365-1369.
43. Hosiawa KA, Wang H, DeVries ME, Garcia B, Liu W, Zhou D et al. CD80/CD86 costimulation regulates acute vascular rejection. J Immunol 2005; 175: 6197-6204.
44. Nolan A, Kobayashi H, Naveed B, Kelly A, Hoshino Y, Hoshino S et al. Differential role for CD80 and CD86 in the regulation of the innate immune response in murine polymicrobial sepsis. PLoS ONE 2009; 4: E6600.
45. Tokita D, Mazariegos GV, Zahorchak AF, Chien N, Abe M, Raimondi G et al. High PD-L1/CD86 ratio on plasmacytoid dendritic cells correlates with elevated T-regulatory cells in liver transplant tolerance. Transplantation 2008; 85: 369-377.